Cargando…
Progress in Personalizing Chemotherapy for Bladder Cancer
Platinum-based chemotherapy is commonly used for the treatment of locally advanced and metastatic bladder cancer. However, there are currently no methods to predict chemotherapy response in this disease setting. A better understanding of the biology of bladder cancer has led to developments of molec...
Autores principales: | Chang, James S., Lara, Primo N., Pan, Chong-Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287014/ https://www.ncbi.nlm.nih.gov/pubmed/22400017 http://dx.doi.org/10.1155/2012/364919 |
Ejemplares similares
-
Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer
por: Lin, Tzu-yin, et al.
Publicado: (2012) -
Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression
por: Delto, Joan C., et al.
Publicado: (2013) -
Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer
por: Abugomaa, Amira, et al.
Publicado: (2020) -
The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment
por: Yu, Chong, et al.
Publicado: (2023) -
Neoadjuvant Chemotherapy in Invasive Bladder Cancer
por: Oliver, R.T.D.
Publicado: (1991)